251 related articles for article (PubMed ID: 2391973)
21. Protection of the immature heart. Temperature-dependent beneficial or detrimental effects of multidose crystalloid cardioplegia in the neonatal rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1990 Feb; 99(2):269-79. PubMed ID: 2299864
[TBL] [Abstract][Full Text] [Related]
22. Is protection of ischemic neonatal myocardium by cardioplegia species dependent?
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1990 Feb; 99(2):280-7. PubMed ID: 2299865
[TBL] [Abstract][Full Text] [Related]
23. Myocardioprotective effects of the combination of ischemic preconditioning with hypothermia and crystalloid cardioplegia in immature rabbits.
Zhu SS; Zhang ZM; Zhang YC; Xu PC; Dong HY; Fan JW; Zeng YM
Sheng Li Xue Bao; 2004 Jun; 56(3):389-96. PubMed ID: 15224156
[TBL] [Abstract][Full Text] [Related]
24. [The effect of coenzyme Q10 and cold cristalloid cardioplegia on hypothermic global ischemia].
Yamamoto H; Yamamoto F
Nihon Kyobu Geka Gakkai Zasshi; 1996 May; 44(5):600-5. PubMed ID: 8964987
[TBL] [Abstract][Full Text] [Related]
25. Brain death-induced cardiac contractile dysfunction and long-term cardiac preservation. Rat heart studies of the effects of hypophysectomy.
Galiñanes M; Smolenski RT; Hearse DJ
Circulation; 1993 Nov; 88(5 Pt 2):II270-80. PubMed ID: 8222165
[TBL] [Abstract][Full Text] [Related]
26. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.
Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273
[TBL] [Abstract][Full Text] [Related]
27. Temperature-dependent cardioprotection of exogenous substrates in long-term heart preservation with continuous perfusion: twenty-four-hour preservation of isolated rat heart with St. Thomas' Hospital solution containing glucose, insulin, and aspartate.
Shimada Y; Yamamoto F; Yamamoto H; Oka T; Kawashima Y
J Heart Lung Transplant; 1996 May; 15(5):485-95. PubMed ID: 8771504
[TBL] [Abstract][Full Text] [Related]
28. Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation.
Rudd DM; Dobson GP
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):198-207. PubMed ID: 19154926
[TBL] [Abstract][Full Text] [Related]
29. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
30. A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine.
Menasché P; Grousset C; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1990 Jul; 100(1):13-21. PubMed ID: 2366551
[TBL] [Abstract][Full Text] [Related]
31. The nitric oxide donor, diethylamine NONOate, enhances preservation of the donor rat heart.
Du ZY; Hicks M; Jansz P; Rainer S; Spratt P; Macdonald P
J Heart Lung Transplant; 1998 Nov; 17(11):1113-20. PubMed ID: 9855451
[TBL] [Abstract][Full Text] [Related]
32. [Sarcoplasmic reticular calcium release and myocardial protection--effects of ryanodine and cold cristalloid cardioplegia on hypothermic global ischemia].
Yamamoto H; Yamamoto F
Nihon Kyobu Geka Gakkai Zasshi; 1995 Jul; 43(7):966-72. PubMed ID: 7561332
[TBL] [Abstract][Full Text] [Related]
33. Long-term preservation of donor hearts: the effect of intra- and extracellular-type of cardioplegic solutions on myocardial high energy phosphate content.
Dyszkiewicz W; Minten J; Flameng W
Mater Med Pol; 1990; 22(3):147-52. PubMed ID: 2132419
[TBL] [Abstract][Full Text] [Related]
34. Improved heart preservation with UW preservation solution.
Swanson DK; Pasaoglu I; Berkoff HA; Southard JA; Hegge JO
J Heart Transplant; 1988; 7(6):456-67. PubMed ID: 3145337
[TBL] [Abstract][Full Text] [Related]
35. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
36. Donor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts.
Dedeoglu BD; Aytac E; Suzer O; Balci H; Uzun H; Seymen P; Seymen HO
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):415-21. PubMed ID: 18583122
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial permeability transition-pore inhibition enhances functional recovery after long-time hypothermic heart preservation.
Rajesh KG; Sasaguri S; Ryoko S; Maeda H
Transplantation; 2003 Nov; 76(9):1314-20. PubMed ID: 14627909
[TBL] [Abstract][Full Text] [Related]
38. Effect of combining phosphodiesterase III inhibitors with St Thomas Hospital's solution used as transplantation preservative solution in isolated rat hearts.
Besirli K; Burhani SM; Arslan C; Suzer O; Sayin AG
Transplant Proc; 2006 Jun; 38(5):1253-8. PubMed ID: 16797275
[TBL] [Abstract][Full Text] [Related]
39. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
[TBL] [Abstract][Full Text] [Related]
40. Protection of the chronic hypoxic immature rat heart during global ischemia.
Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
